Cryopreservation

Ovation Fertility Welcomes Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), as Cincinnati Lab Director

Retrieved on: 
Tuesday, February 20, 2024

Nashville, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), has joined the Ovation® Fertility team as laboratory director of Ovation Fertility Cincinnati, effective February 1, 2024.

Key Points: 
  • Nashville, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), has joined the Ovation® Fertility team as laboratory director of Ovation Fertility Cincinnati, effective February 1, 2024.
  • Dr. Warikoo comes to Ovation from the Bethesda Fertility Center Reproductive Study Lab in Cincinnati, where he has served as scientific director for more than 25 years.
  • “Ovation’s expansion in the Cincinnati area involves a close partnership with our partner physicians at the Institute for Reproductive Health, which combined with Bethesda Fertility Center effective February 1,” says Conor Beardsley, President of Ovation Fertility.
  • He is board certified by the American Board of Bioanalysis as a High Complexity Laboratory Director, Embryology Laboratory Director and Clinical Consultant.

Academy of Adoption and Assisted Reproduction Attorneys Reacts to Alabama Supreme Court Decision Regarding the Status of Embryos

Retrieved on: 
Monday, February 26, 2024

GREENWOOD, Ind., Feb. 26, 2024 /PRNewswire-PRWeb/ -- The Academy of Adoption and Assisted Reproduction Attorneys (AAAA) is a credentialed, nonprofit organization of approximately 500 attorneys, judges, and law professors throughout the United States, Canada and abroad. Our Fellows are distinguished in the legal fields of adoption and assisted reproductive technology. We support and advocate for the rights of individuals to form legally secure families. Understanding the intersection of reproductive technology medicine and the law, AAAA is dedicated to the ethical practice of assisted reproductive technology law and to advancing policy that promotes equitable access to fertility care.

Key Points: 
  • GREENWOOD, Ind., Feb. 26, 2024 /PRNewswire-PRWeb/ -- The Academy of Adoption and Assisted Reproduction Attorneys (AAAA) is a credentialed, nonprofit organization of approximately 500 attorneys, judges, and law professors throughout the United States, Canada and abroad.
  • Our Fellows are distinguished in the legal fields of adoption and assisted reproductive technology.
  • AAAA is deeply concerned and dismayed over the recent Alabama Supreme Court ruling allowing for a wrongful death claim to be asserted in a dispute over cryopreserved embryos.
  • Margaret Swain, AAAA President, Academy of Adoption and Assisted Reproduction Attorneys, (443) 857-3350, [email protected] , www.adoptionart.org
    Nidhi Desai, Director of ART Policy, AAAA, Academy of Adoption and Assisted Reproduction Attorneys, (312) 673-5312, [email protected] , www.adoptionart.org
    View original content to download multimedia: https://www.prweb.com/releases/academy-of-adoption-and-assisted-reproduc...

Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now Controlled by the World's 10 Largest Cord Blood Banking Operators - ResearchAndMarkets.com

Retrieved on: 
Monday, January 22, 2024

There are over 800,000 cord blood units stored in public cord blood banks and more than 6.75 million cord blood and tissue units stored within private banks worldwide.

Key Points: 
  • There are over 800,000 cord blood units stored in public cord blood banks and more than 6.75 million cord blood and tissue units stored within private banks worldwide.
  • Today, nearly all U.S. cord blood banks and approximately one-third of global cord blood banks offer cord tissue storage.
  • The vast majority of the global cord blood market is now controlled by the world's 10 largest cord blood banking operators.
  • It reveals the identities of companies offering cord blood storage, cord blood processing technologies, cord blood expansion technologies, and cord blood therapeutics on a global basis.

Cell Cryopreservation Market Research Report 2024 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 12, 2024

The "Cell Cryopreservation Market Size, Share & Trends Analysis Report By Product (Cell Freezing Media, Equipment), By Application (Stem Cells, Sperm Cells), By End-use (Biobanks, IVF), By Region, And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell Cryopreservation Market Size, Share & Trends Analysis Report By Product (Cell Freezing Media, Equipment), By Application (Stem Cells, Sperm Cells), By End-use (Biobanks, IVF), By Region, And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The increased demand for cost-effective cryopreservation medium has stemmed from increased research & development (R&D) activities to create advanced medicines.
  • For example, Merck KGaA's Sigma Aldrich brand provides frozen media solutions for stem cell applications while ensuring optimal recovery and cell survival, thus, propelling the cryopreservation market growth.
  • Additionally, developments in freezing media formulation and cryopreservation techniques, as well as leveraging cryopreservation freezing media applications in fields such as tissue engineering, cellular treatment, and stem cell research, have driven the market at a substantial rate.

Cryopreservation Best Practices for Cell & Gene Therapy Source Material, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, December 19, 2023

TORONTO, Dec. 19, 2023 /PRNewswire-PRWeb/ -- Cryopreservation, a cornerstone in the field of cell therapy, is the process of preserving biological source materials at ultra-low temperatures to maintain their viability and functionality for future therapeutic applications. This vital technique presents unique challenges and opportunities, and its successful execution is pivotal to the advancement of cell therapies.

Key Points: 
  • This free webinar explains cryopreservation in the context of cell therapy development and manufacturing.
  • The featured speakers will share data related to cell viability with cryopreservation according to different cell types and storage durations.
  • The speakers will also share cryopreservation best practices, why they matter to the cell and gene therapy industry, and why it's important to continue research and innovation.
  • Join this webinar to learn about cryopreservation, a vital step in the manufacturing of today's cell and gene therapies.

Charles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products

Retrieved on: 
Thursday, November 16, 2023

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its CliniPrime™ suite of Good Manufacturing Practice (GMP)-compliant offerings with the launch of CliniPrime Cryopreserved Leukopaks for cell therapy development and manufacturing.

Key Points: 
  • Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its CliniPrime™ suite of Good Manufacturing Practice (GMP)-compliant offerings with the launch of CliniPrime Cryopreserved Leukopaks for cell therapy development and manufacturing.
  • The launch of CliniPrime Cryopreserved Leukopaks completes an already robust portfolio of GMP-compliant leukopaks from Charles River.
  • Charles River provides cellular products and services, creating collaborative relationships with clients as they progress their programs through the development cycle.
  • Clients now have rapid access to fresh or cryopreserved leukopaks to meet any specific program needs.” – Steve Phagoo, Executive Director, Global Cell Solutions, Charles River

Animal Genetics Market Size Valuation Envisaged to Reach USD 11.32 Billion By 2032, With a CAGR of 6.1%: Polaris Market Research

Retrieved on: 
Thursday, November 23, 2023

"According to research report, the global animal genetics market size/share was valued at USD 6.27 Billion in 2022 and is expected to touch USD 11.32 Billion By 2032, growing at a CAGR of 6.1% during the forecast period."

Key Points: 
  • "According to research report, the global animal genetics market size/share was valued at USD 6.27 Billion in 2022 and is expected to touch USD 11.32 Billion By 2032, growing at a CAGR of 6.1% during the forecast period."
  • How Big is Animal Genetics Market Size?
  • The animal genetics market segmentation is primarily based on animal, genetic material, genetic testing services, and region.
  • Animal genetics is one of the principal cornerstones of livestock advancements, together with animal health, nutrition, and husbandry deliberations such as housing.

Legacy Opens Another State-of-The-Art Andrology Lab in Hoboken, New Jersey, Marking Milestone of Freezing Over One Trillion Sperm

Retrieved on: 
Monday, November 20, 2023

NEW YORK, Nov. 20, 2023 /PRNewswire/ -- Legacy, the largest at-home fertility clinic for people with sperm, proudly announced a groundbreaking achievement—freezing over one trillion sperm. In response to increasing demand, the company has officially opened a new lab in Hoboken, NJ.

Key Points: 
  • NEW YORK, Nov. 20, 2023 /PRNewswire/ -- Legacy, the largest at-home fertility clinic for people with sperm, proudly announced a groundbreaking achievement—freezing over one trillion sperm.
  • This milestone solidifies Legacy's position as a leader in at-home male fertility solutions and underscores the company's commitment to investing in state of the art facilities.
  • "Freezing over one trillion sperm is not just a numerical milestone; it's a testament to our rapid growth and big vision," said Khaled Kteily, Legacy's founder and CEO.
  • "The opening of our newest lab in Hoboken proves that Legacy is setting a new standard in male fertility.

HSS Presents New Reproductive Health Research at the ACR Convergence 2023

Retrieved on: 
Tuesday, November 14, 2023

Additional research is planned to assess whether demographics, lifestyle and medical conditions may influence this potential association.

Key Points: 
  • Additional research is planned to assess whether demographics, lifestyle and medical conditions may influence this potential association.
  • This study surveyed women of reproductive age with systemic rheumatic disease about their use of contraceptives.
  • Data were collected on 249 women with reproductive capacity, including 147 with inflammatory arthritis and 102 with lupus-like disorders.
  • This study used data from the electronic health record of patients diagnosed with a rheumatic disease in adolescence, seen at HSS, to look at factors associated with HPV vaccination.

Cryoport Reports Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, November 8, 2023

A total of six Cryoport supported Biologic License Applications (BLAs) or Marketing Authorization Applications (MAAs) were filed in the third quarter of 2023.

Key Points: 
  • A total of six Cryoport supported Biologic License Applications (BLAs) or Marketing Authorization Applications (MAAs) were filed in the third quarter of 2023.
  • Biopharma/Pharma revenue was $47.0 million, down 3% or $1.6 million for Q3 2023 compared to $48.6 million for Q3 2022.
  • Revenue from the support of commercial cell and gene therapies increased by $2.3 million, or 54%, to $6.6 million for Q3 2023.
  • Reproductive Medicine revenue was $2.3 million for Q3 2023, consistent with Q3 2022, reflecting sustained demand for our CryoStork® logistics solutions.